Related Experiment Video
Updated: Sep 10, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Overcoming data management challenges in oncology research: Lessons from an NHS, industry, technology start-up and
Alicia-Marie Conway1, Matthew Concannon2, Steven Brown2
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Nucleic Acid Biomarker Team, Cancer Research UK, National Biomarker Centre, The University of Manchester, Manchester, UK.
Background:
The integration of large-scale genomic and multimodal data is critical to advancing oncology research. However, challenges related to data storage, sharing, and governance hinder its effective use. We share experience from conducting a multi-site, cross-industry UK project utilising large-scale genomic data obtained from tissue and liquid biopsies from patients with cancer, to produce recommendations for enabling and optimising the use of multimodal data in oncology research.
Methods:
A collaborative approach involving NHS Trusts, industry, start-ups, and academic partners was adopted to develop a robust data management strategy. A data lake architecture was selected as the centralised repository to store and share diverse datasets securely. Key factors influencing the selection and implementation of this solution included data storage requirements, access control, ownership, and information governance. Processes for planning, deploying, and maintaining the data lake infrastructure were documented and evaluated.
Results:
The data lake enabled secure, compliant, and federated storage of large-scale genomic and clinical data. Successful implementation required early engagement of stakeholders and the establishment of clear data governance frameworks. Lessons learned highlighted the importance of aligning technical solutions with governance, security, and accessibility requirements across diverse partners.
Conclusions:
Effective management of multimodal data in oncology requires early planning, multi-stakeholder engagement (among National Health Service [NHS] Trusts, industry, start-up collaborators, and academic institutions), and robust governance. The data lake model demonstrated a scalable and compliant approach to enabling secure, collaborative research using genomic data, providing a template for future initiatives in precision oncology.
Related Concept Videos
Treatment Resistant Cancers
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

